The CHM gene helps cells move materials to the right place, especially in the light sensing tissue at the back of the eye. When it does not work properly, people can develop choroideremia, an inherited eye condition that often starts with night blindness and slowly narrows side vision over time. The protein made by this gene helps your cells manage transport signals needed to keep retinal cells healthy. Because CHM is on the X chromosome, vision changes often affect males more strongly, while some female carriers have milder retinal changes.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes hold the code for proteins, which are the parts of cells that do much of the work. Other genes mainly guide when certain processes happen, where they happen, and how active they are. In combination, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To look into this topic in more detail, you can visit the LearnHub.
Overview
CHMGene function
What if the gene works
The CHM gene helps cells move materials to the right place. It is especially important in the retina, where this transport supports the retinal pigment layer and light sensing cells.
Risk
What if the gene does not work
Pathogenic variants in the CHM gene usually cause choroideremia, with worsening night blindness and gradual narrowing of vision that can progress to marked sight loss. Milder and more severe variants can affect when symptoms begin and how fast vision changes.
Treatment
What does that mean for your treatment
For pathogenic variants in the CHM gene, no treatment or drug choice guided specifically by the CHM gene is currently established in clinical guidelines. The CHM gene is being studied as a target for retinal gene replacement therapy, but this remains investigational.
Conditions associated with CHM
Gene function
What if the gene works
Inside your cells, the CHM gene helps keep the cell’s delivery system running smoothly. It supports small transport proteins called RAB proteins, which guide where cargo moves inside the cell. Understanding how the CHM gene works in the body helps explain how cells stay organized day to day.
The CHM gene helps prepare RAB proteins, which act like traffic guides for cargo moving inside cells. It brings them to the cell machinery that adds a small fat tag so they can work in the right place.
A small fat tag helps RAB proteins attach to cell membranes, where many transport steps begin. This gives cells a reliable way to direct packages from one compartment to another.
By supporting RAB proteins, the CHM gene helps cells recycle membranes and move proteins and other materials to where they are needed. This steady flow is part of normal day to day cell function.
What is a variant?
A genetic variant is a small difference in a gene’s DNA sequence. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
When clinicians describe how variants influence the CHM gene's function, they usually mean that changes in the CHM gene shorten or destabilize the REP-1 protein, or stop cells from making it at all. This disrupts the addition of small fat-like anchors to key transport proteins, so they do not move normally inside cells. More severe variants often remove most REP-1 activity, while milder variants may leave some function. In choroideremia, less remaining activity can be linked to earlier or more marked vision loss.
How variants are linked to conditions
Pathogenic variants in the CHM gene cause choroideremia, an inherited eye condition that gradually narrows peripheral vision and can later reduce central sight. The CHM gene choroideremia association is well established, and a disease-causing variant can confirm the diagnosis. The condition mainly affects males, while some females who carry the variant may have mild retinal changes or milder vision symptoms.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common across the general population. Most do not have a direct effect on health and simply represent natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CHM, risk is mainly shaped by whether a disease-causing variant is present and, in many families, whether the person is male or female. In males with a harmful CHM variant, the chance of developing choroideremia is high, while females may have milder or more variable changes. There is not enough evidence to say that lifestyle factors meaningfully lower or raise this genetic risk.
Inheritance of CHM variants
For families asking how CHM variants are inherited, the usual pattern is X linked recessive. Because the CHM gene is on the X chromosome, a mother carrying a CHM variant can pass it to each child, with each son having a 50% chance of inheriting the variant and being affected, and each daughter having a 50% chance of being a carrier. A father with a CHM variant passes his X chromosome to all daughters and none of his sons, so all daughters inherit the variant and sons do not inherit it from him.
What does my CHM result mean for my family?
For CHM, family impact usually follows an X-linked pattern. In practical terms, males in the family may be more likely to develop the vision condition linked to CHM, while females may carry the gene change and can sometimes have milder eye findings. Close relatives on the mother’s side may also carry the same result, so family testing can help clarify who else may be affected or be a carrier.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the CHM gene, CHM genetic testing uses a blood or saliva sample to read the gene’s DNA. Labs often use sequencing, and sometimes checks for missing or extra pieces, to identify variants and help clarify whether a result explains symptoms or carrier status.
When should I consider getting a genetic test?
Consider CHM genetic testing if there is a family history of choroideremia or unexplained inherited vision loss, especially night blindness and slowly narrowing side vision. It can help confirm the cause of retinal disease, clarify who in the family may carry the change, and help with family planning and specialist eye care.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. Many factors also shape how the body works over time, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information adds context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, these results can also help place a person’s experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, transports, or responds to a drug. This is common and can help explain why the same treatment works well for one person, seems less effective for another, or causes more side effects in some people.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medicines. It studies connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support more informed, more individualized treatment decisions. If you want to read more about this topic, you can learn more in the LearnHub.
Drugs influenced by the CHM gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so if you have concerns about side effects, new symptoms after starting a medicine, or possible interactions, talk with your doctor.
History
Choroideremia was described in the medical literature in the 1800s as a vision condition that seemed to run in families, especially affecting boys and men. For many years, doctors recognized it by its pattern of night blindness and gradual vision loss before the genetic cause was known. Initially understood only through visible traits, later recognized as tied to a specific gene, it became one of the inherited retinal conditions mapped to the X chromosome in the late 20th century. In 1990, researchers identified the CHM gene as the cause of X linked choroideremia, which helped confirm why the condition followed a clear family pattern. From these first observations, research expanded steadily, including genetic testing and early gene therapy studies that brought wider attention to this rare eye condition.